µå·¯±×ÀÎÆ÷¸ÞÀÎ
 

»óº´Äڵ忡 µû¸¥ »óº´¸íÀ» È®ÀÎ ÇϽǼö ÀÖ½À´Ï´Ù.  
»óº´ÄÚµå ÇÑ±Û»óº´¸í ¿µ¹®»óº´¸í
Y464 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â À̹̳뽺ƿº¥ Iminostilbenes causing adverse effects in therapeutic use
Y464 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ä«¹Ù¸¶Á¦ÇÉ Carbamazepine causing adverse effects in therapeutic use
Y465 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¹ßǪ·ÎÀÍ »ê Valproic acid causing adverse effects in therapeutic use
Y466 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ Ç×°£ÁúÁ¦ Other and unspecified antiepileptics causing adverse effects in therapeutic use
Y467 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÇׯÄŲ½¼Á¦ Antiparkinsonism drugs causing adverse effects in therapeutic use
Y467 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¾Æ¸¸Å¸µò Amantadin causing adverse effects in therapeutic use
Y468 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×°­Á÷Á¦ Antispasticity causing adverse effects in therapeutic use
Y47 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÁøÁ¤Á¦, ¼ö¸éÁ¦ ¹× Ç׺ҾÈÁ¦ Sedatives, hypnotics and antianxiety drugs causing adverse effects in therapeutic use
Y470 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ¹ÙºñÃò·¹ÀÌÆ® Barbiturates, NEC causing adverse effects in therapeutic use
Y471 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â º¥Á¶µð¾ÆÁ¦ÇÉ Benzodiazepines causing adverse effects in therapeutic use
Y472 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ŭ·Î¶öÀ¯µµÃ¼ Cloral derivatives causing adverse effects in therapeutic use
Y473 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÆÄ¶ó¾Ëµ¥È÷µå Paraldehyde causing adverse effects in therapeutic use
Y474 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ºê·ÒÈ­ÇÕ¹° Bromine compounds causing adverse effects in therapeutic use
Y475 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº È¥ÇÕ ÁøÁ¤Á¦ ¹× ÃÖ¸éÁ¦ Mixed sedatives and hypnotics, NEC causing adverse effects in therapeutic use
Y478 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ÁøÁ¤Á¦, ÃÖ¸éÁ¦ ¹× Ç׺ҾÈÁ¦ Other sedatives, hypnotics and antianxiety drugs causing adverse effects in therapeutic use
Y478 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¸ÞŸÄí¾Æ·Ð Methaqualone causing adverse effects in therapeutic use
Y479 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ó¼¼ºÒ¸íÀÇ ÁøÁ¤Á¦, ÃÖ¸éÁ¦ ¹× Ç׺ҾÈÁ¦ Sedatives, hypnotics and antianxiety drug, unspecified causing adverse effects in therapeutic use
Y479 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¼ö¸éÁ¦ NOS Sleeping draught, drug and tablet NOS causing adverse effects in therapeutic use
Y48 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¸¶ÃëÁ¦ ¹× °¢Á¾ Ä¡·á¿ë °¡½º Anesthetics and therapeutic gases causing adverse effects in therapeutic use
Y480 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÈíÀÔ¸¶ÃëÁ¦ Inhaled anesthetics causing adverse effects in therapeutic use
1911  [1912] 1913  1914  1915  1916  1917  1918  1919  1920